TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI ®  (ublituximab-xiiy), to be presented at the Americas Committee for Treatment and Research in ...

BACKGROUND: The disruption of the blood–brain barrier (BBB) is a central pathogenic event in many central nervous system disorders. However, the mechanisms regulating BBB function remain incompletely ...

The thymus peptide upregulated 1,198 genes tied to energy metabolism, DNA repair, and cell cycle regulation. The Thymus ...

New York researchers have taken another step in the lengthy battlle against Alzheimer’s disease, finding a way to slow memory loss and improve learning in mice. The key is in clearing harmful amyloid ...

Over the past two decades, researchers have learned that DNA inside the cell nucleus naturally folds into a network of ...